| ASSET | YEAR | % RETURN |
|---|---|---|
Arrowhead Pharmaceuticals (ARWR) | 2015 | -20.23% |
Arrowhead Pharmaceuticals (ARWR) | 2016 | -74.04% |
Arrowhead Pharmaceuticals (ARWR) | 2017 | 135.9% |
Arrowhead Pharmaceuticals (ARWR) | 2018 | 236.59% |
Arrowhead Pharmaceuticals (ARWR) | 2019 | 421.63% |
Arrowhead Pharmaceuticals (ARWR) | 2020 | 20.61% |
Arrowhead Pharmaceuticals (ARWR) | 2021 | -12.84% |
Arrowhead Pharmaceuticals (ARWR) | 2022 | -38.78% |
Arrowhead Pharmaceuticals (ARWR) | 2023 | -25% |
Arrowhead Pharmaceuticals (ARWR) | 2024 | -38.36% |
Arrowhead Pharmaceuticals (ARWR) | 2025 | 90.71% |
